Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been found that desoxycholic acid-3- (1), -12- (2) and -3,12-bis-beta-D-glucuronide (3) exert a potent allosteric effect on the
beta-glucuronidase
activity, which results in non-competitive inhibition of this enzyme in the pH range from 4.5 to nearly 5.5, and in its activation in the pH range from 6 to 7.4.
Desoxycholic acid
as well as as glycodesoxycholic acid and taurodesoxycholic acid caused a slight activation of
beta-glucuronidase
in the total pH range from 4.5 to 7.4. The dependence of these effects upon the pH value and the amount of the respective desoxycholic acid derivative used was demonstrated by the example of the cleavage of phenolpthalein-beta-D-glucuronide by
beta-glucuronidase
in the presence of the desoxycholid acid derivatives. The results obtained permit to interpret the cleavage of 1 by
beta-glucuronidase
. The cleavage of 1 by
beta-glucuronidase
is sufficiently rapid to use 1 as a CMT-selectin in the cancer multistage therapy according to Ardenne [1, 2, 5]. In contrast, no cleavage was observed in 2 and 3. To follow the cleavage of 1, a simple method has been developed which permits to determine mixtures of 1 and desoxycholic acid.
...
PMID:[Interactions between desoxycholic acid glucuronides and glucuronidase (author's transl)]. 745 46